Syndax Pharmaceuticals, Inc.SNDXNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Trend
Trending higher.
Left:
||||
Year-over-year research & development expense growth
Latest
48.22%
Near historical average
Average (9y)
48.63%
Historical baseline
Range
High:231.61%
Low:-28.47%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 48.22% |
| 2023 | 37.58% |
| 2022 | 34.28% |
| 2021 | 74.97% |
| 2020 | 17.31% |
| 2019 | -28.47% |
| 2018 | 24.70% |
| 2017 | 52.22% |
| 2016 | 231.61% |
| 2015 | -6.15% |